 | ||
 |
 |
 |
 |
 |
 |
|
DispersinB®
DispersinB® is an antibiofilm enzyme, which inhibits and disperses biofilms of major bacterial pathogens. It was discovered by Dr. Jeffrey B. Kaplan, Department of Oral Microbiology, New Jersey Dental School, NJ, USA. The discovery of this enzyme with the support of the NIH (USA) grant was listed in the "NIH Annual Performance Report of 2004" as one of the thirteen achievements of the year. The unique ability of this enzyme to specifically inhibit biofilm formation without affecting bacterial growth and to disperse preformed biofilms makes it a first of its kind antibiofilm enzyme.
Kane Biotech Inc. has an exclusive worldwide license agreement with the University of Medicine and Dentistry of New Jersey, NJ, USA to commercialize DispersinB® technology for human, animal, agricultural and industrial applications. The US patent on this technology has already been issued (U.S. Pat. No.7,294,497).
Kane Biotech is presently evaluating DispersinB® alone, and in combination with other antimicrobial agents to develop a proprietary wound care gel and medical device coating. Kane continues to evaluate and develop cutting edge technologies independently, and in cooperation with leading academic institutions.
For a complete technical review of DispersinB® click here
